Omicron subvariants resistant to key antibody treatments are increasing every week in the U.S. - Earth News Report
A rendering of COVID-19 new Omicron sub-variant BQ.1.1Koto_feja | E+ | Getty Images Two omicron subvariants that are resistant to key antibody treatments are on the rise in the U.S., according to data from the Centers for Disease Control and Prevention. The subvariants BQ.1 and BQ.1.1 now represent 27% of infections in the U.S., a
